Mary-Elizabeth M on Muck Rack

Mary-Elizabeth M

As seen in: Nature, Ash Publications
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mary-Elizabeth

Contact Mary-Elizabeth, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Novel Data Analytics Identify Predictors of Quality-of-Life Trajectories in Patients with AML or High-Risk Myeloid Neoplasms

|
By Hematologic Malignancies, Mary-Elizabeth M, Lavista Ferres
| Ash Publications
Gauthier:Celgene (A BMS Company): Research Funding; Juno Therapeutics - A BMS Company: Research Funding; Multerra Bio: Consultancy; Sobi: Research Funding; Legend Biotech: Consultancy; Kite Pharma: Consultancy. Furtuna:Microsoft: Current Employment. Mangiavacchi:Microsoft: Current Employment. Gholami:Microsoft: Current Employment. Lavista Ferres:Microsoft: Current Employment. Dodhia:Microsoft: Current Employment.
Open in Who Shared Issue with article?

Physician and patient perceptions on randomization of treatment intensity for unfit adults with acute myeloid leukemia and other high-grade myeloid neoplasm | Leukemia

|
By Mary-Elizabeth M, Kelsey-Leigh A
| Nature Verified
This is a preview of subscription content Access options Subscribe to Journal Get full journal access for 1 year $119.00 only $9.92 per issue All prices are NET prices. VAT will be added later in the checkout. Tax calculation will be finalised during checkout. Buy article Get time limited or full article access on ReadCube. $32.00 All prices are NET prices. Additional access options: Log in Learn about institutional subscriptions References Kahn SB, Begg CB, Mazza JJ, Bennett JM, Bonner H, Glick JH.
Open in Who Shared Issue with article?

Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies - Leukemia

|
By Mary-Elizabeth M
| Nature Verified
This is a preview of subscription content Access options Subscribe to Journal Get full journal access for 1 year $119.00 only $9.92 per issue All prices are NET prices. VAT will be added later in the checkout. Tax calculation will be finalised during checkout. Buy article Get time limited or full article access on ReadCube. $32.00 All prices are NET prices. Additional access options: Log in Learn about institutional subscriptions Fig. 1: Kaplan–Meier curves for overall survival. References 1.
Open in Who Shared Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified